Analysts’ Downgrades for February, 8th (ABEO, ADAP, ASHTY, AU, BBD, BLCM, BRS, CBM, CEVA, CONN), Report finds

Analysts’ Downgrades for February, 8th (ABEO, ADAP, ASHTY, AU, BBD, BLCM, BRS, CBM, CEVA, CONN), Report finds

Analysts’ downgrades for Wednesday, February 8th:

Abeona Therapeutics (NASDAQ:ABEO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States. “

Adaptimmune Therapeutics PLC (NASDAQ:ADAP) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom. “

Ashtead Group (NASDAQ:ASHTY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ashtead Group Plc is an equipment company which provides rental solutions primarily in United States and United Kingdom. The company’s operating segments consists of Sunbelt Rentals and A-Plant. Sunbelt Rentals provides pump and power, climate control and scaffolding services. A-Plant business operates through Eve Trakway Limited, which constructs temporary roadways and barriers; PSS, which offers trenchless technology and fusion services and FLG services. Ashtead Group Plc is headquartered in London, the United Kingdom. “

AngloGold Ashanti Limited (NYSE:AU) was downgraded by analysts at Zacks Investment Research from a buy rating to a strong sell rating. According to Zacks, “AngloGold Limited is the largest gold producer at 7 million ounces a year, with reserves of 126 m oz. The company has operations in six countries on three continents, some of which are joint ventures, as well as exploration activities in ten countries. AngloGold can be financially characterized by high cash generation, substantial reinvestment in long-term growth and the payment of significant dividends. The company distinguishes itself from its producer peer group through its active involvement in the development of the gold market, particularly in Asia. “

Banco Bradesco SA (NYSE:BBD) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Banco Bradesco’s main activities are the provision of banking and insurance services such as private and industrial credit loans, credit cards, mortgaged loans, 24 hour banking, health and life insurance, leasing, pension fund management and services for stock market investors. “

Bellicum Pharmaceuticals (NASDAQ:BLCM) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. The Company’s lead clinical product candidate is BPX-501, an adjunct T-cell therapy in multiple Phase I/II clinical trials. It is also developing BPX-201, a dendritic cell cancer vaccine, which is in a Phase I clinical trial for the treatment of metastatic castrate-resistant prostate cancer. Bellicum Pharmaceuticals, Inc. is based in Houston, Texas. “

Bristow Group (NYSE:BRS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bristow Group Inc. is a leading provider of helicopter services to the worldwide energy industry. Through its subsidiaries, affiliates and joint ventures, the Company has major transportation operations in the U.S. Gulf of Mexico and the North Sea, and in most of the other major offshore oil and gas producing regions of the world, including Alaska, Australia, Brazil, Mexico, Nigeria, Russia and Trinidad. Additionally, the Company is a leading provider of production management services for oil and gas production facilities in the U.S. Gulf of Mexico. “

Cambrex Corporation (NYSE:CBM) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Cambrex Corporation manufactures and markets a broad line of specialty chemicals and commodity chemical intermediates and also manufactures chemicals to customer specifications. There are five product categories: pharmaceutical bulk actives; pharmaceutical intermediates; organic intermediates; performance enhancers; and polymer systems. “

CEVA (NASDAQ:CEVA) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CEVA Inc is the leading licensor of DSP cores and integrated applications to the semiconductor industry. CEVA markets a portfolio of DSP IP in three integrated areas: CEVA DSPs; CEVA-Xpert Open Framework Environment; CEVA-Xpert Applications; supported by Xpert-Integration services. “

Conn’s (NASDAQ:CONN) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Conns Inc is a specialty retailer currently operating retail locations in Texas and Louisiana. It sells major home appliances, including refrigerators, freezers, washers, dryers and ranges, and a variety of consumer electronics, including projection, plasma and LCD televisions, camcorders, VCRs, DVD players and home theater products. They also sell home office equipment, lawn and garden products and bedding, and continue to introduce additional product categories for the home to help increase same store sales and to respond to their customers’ product needs. “

Curis (NASDAQ:CRIS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis’ product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease. “

Silver Wheaton Corp (NYSE:SLW) (TSE:SLW) was downgraded by analysts at Goldman Sachs Group, Inc. (The) from a buy rating to a neutral rating.

Sterling Construction Company (NASDAQ:STRL) was downgraded by analysts at KeyCorp to an overweight rating.

Related posts

Leave a Comment

Analysts’ Downgrades for February, 8th (ABEO, ADAP, ASHTY, AU, BBD, BLCM, BRS, CBM, CEVA, CONN)

Analysts’ Downgrades for February, 8th (ABEO, ADAP, ASHTY, AU, BBD, BLCM, BRS, CBM, CEVA, CONN)

Analysts’ downgrades for Wednesday, February 8th:

Abeona Therapeutics (NASDAQ:ABEO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States. “

Adaptimmune Therapeutics PLC (NASDAQ:ADAP) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom. “

Ashtead Group (NASDAQ:ASHTY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ashtead Group Plc is an equipment company which provides rental solutions primarily in United States and United Kingdom. The company’s operating segments consists of Sunbelt Rentals and A-Plant. Sunbelt Rentals provides pump and power, climate control and scaffolding services. A-Plant business operates through Eve Trakway Limited, which constructs temporary roadways and barriers; PSS, which offers trenchless technology and fusion services and FLG services. Ashtead Group Plc is headquartered in London, the United Kingdom. “

AngloGold Ashanti Limited (NYSE:AU) was downgraded by analysts at Zacks Investment Research from a buy rating to a strong sell rating. According to Zacks, “AngloGold Limited is the largest gold producer at 7 million ounces a year, with reserves of 126 m oz. The company has operations in six countries on three continents, some of which are joint ventures, as well as exploration activities in ten countries. AngloGold can be financially characterized by high cash generation, substantial reinvestment in long-term growth and the payment of significant dividends. The company distinguishes itself from its producer peer group through its active involvement in the development of the gold market, particularly in Asia. “

Banco Bradesco SA (NYSE:BBD) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Banco Bradesco’s main activities are the provision of banking and insurance services such as private and industrial credit loans, credit cards, mortgaged loans, 24 hour banking, health and life insurance, leasing, pension fund management and services for stock market investors. “

Bellicum Pharmaceuticals (NASDAQ:BLCM) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. The Company’s lead clinical product candidate is BPX-501, an adjunct T-cell therapy in multiple Phase I/II clinical trials. It is also developing BPX-201, a dendritic cell cancer vaccine, which is in a Phase I clinical trial for the treatment of metastatic castrate-resistant prostate cancer. Bellicum Pharmaceuticals, Inc. is based in Houston, Texas. “

Bristow Group (NYSE:BRS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bristow Group Inc. is a leading provider of helicopter services to the worldwide energy industry. Through its subsidiaries, affiliates and joint ventures, the Company has major transportation operations in the U.S. Gulf of Mexico and the North Sea, and in most of the other major offshore oil and gas producing regions of the world, including Alaska, Australia, Brazil, Mexico, Nigeria, Russia and Trinidad. Additionally, the Company is a leading provider of production management services for oil and gas production facilities in the U.S. Gulf of Mexico. “

Cambrex Corporation (NYSE:CBM) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Cambrex Corporation manufactures and markets a broad line of specialty chemicals and commodity chemical intermediates and also manufactures chemicals to customer specifications. There are five product categories: pharmaceutical bulk actives; pharmaceutical intermediates; organic intermediates; performance enhancers; and polymer systems. “

CEVA (NASDAQ:CEVA) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CEVA Inc is the leading licensor of DSP cores and integrated applications to the semiconductor industry. CEVA markets a portfolio of DSP IP in three integrated areas: CEVA DSPs; CEVA-Xpert Open Framework Environment; CEVA-Xpert Applications; supported by Xpert-Integration services. “

Conn’s (NASDAQ:CONN) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Conns Inc is a specialty retailer currently operating retail locations in Texas and Louisiana. It sells major home appliances, including refrigerators, freezers, washers, dryers and ranges, and a variety of consumer electronics, including projection, plasma and LCD televisions, camcorders, VCRs, DVD players and home theater products. They also sell home office equipment, lawn and garden products and bedding, and continue to introduce additional product categories for the home to help increase same store sales and to respond to their customers’ product needs. “

Curis (NASDAQ:CRIS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis’ product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease. “

Silver Wheaton Corp (NYSE:SLW) (TSE:SLW) was downgraded by analysts at Goldman Sachs Group, Inc. (The) from a buy rating to a neutral rating.

Sterling Construction Company (NASDAQ:STRL) was downgraded by analysts at KeyCorp to an overweight rating.

Related posts

Leave a Comment